SPG Microstimulator System Market - Global Industry Analysis

SPG Microstimulator System Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Category: Medical Device Report Format : PDF Report Code: ZMR-1854 Status : Upcoming


Global SPG Microstimulator System Market: Overview

The SPG microstimulator system is used for the patients those who are suffering from a chronic headache or a migraine to get a relief from the pain as the standard treatment for these patients are inadequate. The episodic unilateral pain in the periorbital region is termed as cluster headaches. This disease is mainly found in the male population and this headache attacks may last from few minutes to several hours. The treatment using SPG microstimulation systems is an excellent treatment option for the patients which become resistant to triptans. The only SPG microstimulator system that is approved by the US and the European Union is Pulsante System.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global SPG Microstimulator System Market: Segmentation

The market for SPG microstimulator system is fragmented into indication and end user. On the basis of indication, the global market is segregated into a migraine, cluster headache, and others. Depending on the end user, the market is categorized into hospitals, specialty clinics, and ambulatory surgical centers.

Global SPG Microstimulator System Market: Growth Factors

The major factor that will contribute towards the SPG microstimulator market growth in the future years is the increasing number of cases of rhinorrhea and chronic cluster headache. There are tests being conducted to check whether SPG microstimulator device can be used as a substitute to occipital nerve stimulation and deep brain stimulation devices. If these studies and test are completed successfully then the deep brain stimulation devices can be replaced, as these devices involve risks and even chances of death. Expanded CE Mark approval is required for the use of the SPG microstimulator system on the patients suffering from chronic headaches. But till now there has been limited product approvals in the US and Europe for SPG microstimulation systems. This is the factor that is restraining the growth of the market for SPG microstimulator systems.

Global SPG Microstimulator System Market: Regional Analysis

The market for the SPG microstimulator is geographically segmented into Asia-Pacific, the Middle East and Africa, North America, Western Europe, Eastern Europe, and Latin America. It is European region that is dominating the SPG microstimulator systems market. The only key player in SPG microstimulator system market is making effort and is investing rapidly in order to expand its presence in the European region so that they are able to capture the increasing volume of the patients that are suffering from a chronic cluster headache. It is expected the North America will soon become the next largest market for SPG microstimulation system after Europe. In the US, the market player Autonomic Technologies, Inc., is conducting researches and IDE studies for the SPG microstimulation system.

Global SPG Microstimulator System Market: Competitive Players

The only key market player that is right now operating in the SPG microstimulator market is Autonomic Technologies, Inc. The Pulsante™ SPG Microstimulator System is developed by Autonomic Technologies, Inc. for relieving the acute pain of a cluster headache.

Global SPG Microstimulator System Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets


Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social